Gen Ilac Veglik Urunlerinayi ve Ticaret AS (IST:GENIL) Other Current Liabilities: ₺925 Mil (As of Mar. 2026)


IST:GENIL Gen Ilac Ve Saglik Urunleri Sanayi ve Ticaret AS IST:GENIL
87 GF Score
Price ₺9.05
GF Value ₺8.15
Valuation Modestly Overvalued
! 5 Warning Signs
View Full Analysis

What is Gen Ilac Veglik Urunlerinayi ve Ticaret AS Other Current Liabilities?

Gen Ilac Veglik Urunlerinayi ve Ticaret AS IST:GENIL 87 Other Current Liabilities is ₺925 Mil as of Mar. 2026. GuruFocus rates IST:GENIL with a GF Score™ of 87/100 and a GF Value™ of ₺8.15 (Modestly Overvalued). The stock has 5 warning signs investors should review.

Gen Ilac Veglik Urunlerinayi ve Ticaret AS's other current liabilities for the quarter that ended in Mar. 2026 was ₺925 Mil.

Gen Ilac Veglik Urunlerinayi ve Ticaret AS's quarterly other current liabilities increased from Sep. 2025 (₺1,334 Mil) to Dec. 2025 (₺1,621 Mil) but then declined from Dec. 2025 (₺1,621 Mil) to Mar. 2026 (₺925 Mil).

Gen Ilac Veglik Urunlerinayi ve Ticaret AS's annual other current liabilities increased from Dec. 2023 (₺730 Mil) to Dec. 2024 (₺972 Mil) and increased from Dec. 2024 (₺972 Mil) to Dec. 2025 (₺1,621 Mil).

Gen Ilac Veglik Urunlerinayi ve Ticaret AS Other Current Liabilities Related Terms

Gen Ilac Veglik Urunlerinayi ve Ticaret AS Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gen Ilac Veglik Urunlerinayi ve Ticaret AS Other Current Liabilities Chart

Gen Ilac Veglik Urunlerinayi ve Ticaret AS Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Liabilities
Get a 7-Day Free Trial 29.32 58.81 730.41 972.29 1,620.99

Gen Ilac Veglik Urunlerinayi ve Ticaret AS Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 748.82 1,051.91 1,334.34 1,620.99 924.77
IST:GENIL
87GF Score
Gen Ilac Ve Saglik Urunleri Sanayi ve Ticaret AS IST:GENIL
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Gen Ilac Veglik Urunlerinayi ve Ticaret AS Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of ₺925 Mil mean?
Gen Ilac Veglik Urunlerinayi ve Ticaret AS (IST:GENIL) has a Other Current Liabilities of ₺925 Mil as of Mar. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Gen Ilac Veglik Urunlerinayi ve Ticaret AS.
Is Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Other Current Liabilities too high?
Gen Ilac Veglik Urunlerinayi ve Ticaret AS's current Other Current Liabilities is ₺925 Mil. Overall, Gen Ilac Veglik Urunlerinayi ve Ticaret AS has a GF Score™ of 87/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Other Current Liabilities compare to ZTS and UTHR?
Gen Ilac Veglik Urunlerinayi ve Ticaret AS's Other Current Liabilities of ₺925 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Drug Manufacturers company?
A good Other Current Liabilities depends on the Drug Manufacturers industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Gen Ilac Veglik Urunlerinayi ve Ticaret AS. Gen Ilac Veglik Urunlerinayi ve Ticaret AS's current Other Current Liabilities is ₺925 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gen Ilac Veglik Urunlerinayi ve Ticaret AS stock overvalued right now?
Based on GuruFocus' analysis, Gen Ilac Veglik Urunlerinayi ve Ticaret AS (IST:GENIL) is currently considered Modestly Overvalued. The stock's GF Value™ is ₺8.15, compared to a current price of ₺9.05 — trading 11% above its estimated fair value. The current Other Current Liabilities is ₺925 Mil. Gen Ilac Veglik Urunlerinayi ve Ticaret AS's overall GF Score™ is 87/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Gen Ilac Veglik Urunlerinayi ve Ticaret AS (IST:GENIL), the current Other Current Liabilities is ₺925 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Gen Ilac Veglik Urunlerinayi ve Ticaret AS (IST:GENIL) Overvalued in 2026?

Based on GuruFocus' analysis, Gen Ilac Veglik Urunlerinayi ve Ticaret AS stock appears to be overvalued. The current stock price of ₺9.05 is trading 11% above its estimated GF Value™ of ₺8.15. GuruFocus considers Gen Ilac Veglik Urunlerinayi ve Ticaret AS to be Modestly Overvalued.

Key valuation signals for IST:GENIL:

  • Other Current Liabilities: ₺925 Mil
  • GF Value™: ₺8.15 vs. price of ₺9.05 (11% above fair value)
  • GF Score™: 87/100 with 5 warning signs

No single metric tells the full story. See the IST:GENIL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Gen Ilac Veglik Urunlerinayi ve Ticaret AS Business Description

Address Mustafa Kemal Mahallesi 2119.Sk. No:3, Cankaya, Ankara, TUR, 06520
Gen Ilac Ve Saglik Urunleri Sanayi ve Ticaret AS is a specialty pharmaceuticals company in Turkey. Its locally manufactured products include Cajex, Contra-K, Epamor, Genkort, Ilopera, among others, while imported products include AvonexPEN, Plegridy, Tecfidera, Regen-D among others.
87GF Score

Get the complete analysis for IST:GENIL

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₺9.05
Price
₺8.15
GF Value